Search

Eyewire News: The Podcast

Eyewire News: The Podcast

04.01.26

Biogen Enters GA Treatment Market After Major Acquisition

Pharma giant Biogen announces its intention to acquire Apellis in a multi-billion dollar deal; a recently approved first-of-its-kind presbyopia drop is commercially launched; and Kodiak Sciences releases phase 3 data for its diabetic retinopathy drug candidate. Learn more about your ad choices. Visit megaphone.fm/adchoices

View full description +

MORE EPISODES

04.01.26

Biogen Enters GA Treatment Market After Major Acquisition

03.25.26

Interview with ASCRS Executive Director Steve Speares

03.18.26

Alcon and Lensar Call Off Merger

03.04.26

FDA Agrees to Review Phentolamine for Presbyopia

02.25.26

Zeiss Launches App to Improve Workflow

02.18.26

Ocular Releases Phase 3 Data for Wet AMD Candidate Axpaxli

02.11.26

Study: Metformin May Lower AMD Progression

02.04.26

First Dual-Agent Eye Drop for Presbyopia Approved

Show More

Anterior 3D Cataract Cornea General Glaucoma Optometry Pediatric Refractive/LVC Residents & Fellows Retina Retina 3D